Nursing Homes, Once Hotspots, Far Outpace U.S. in Covid Declines
The New York Times · 4 minThroughout the pandemic, there has been perhaps nowhere more dangerous than a nursing home.
Stay informed with this curated guide to the global outbreak. For official U.S. guidelines and health updates, visit cdc.gov.
Throughout the pandemic, there has been perhaps nowhere more dangerous than a nursing home.
Combining traditional medicine and modern science, these courageous doctors have risen to the challenge.
The first way to fight a new virus would once have been opening the windows.
Scientists at the Food and Drug Administration said Wednesday that the single-shot Covid-19 vaccine developed by Johnson & Johnson is effective and prevents hospitalizations from the disease.
A coronavirus variant that emerged in mid-2020 and surged to become the dominant strain in California not only spreads more readily than its predecessors, but also evades antibodies generated by COVID-19 vaccines or prior infection and it’s associated with severe illness and death, researchers said.
How do we wrap our minds around the fact that nearly half a million people have died of COVID-19 in the United States alone? The nation is on the cusp of that milestone: 500,000 lives lost, in just one year.
Sixty years ago, the scientists who were pioneering the technology that would make today's COVID-19 vaccines possible were mocked and dismissed.
President Biden has promised enough doses for all American adults by this summer. There’s not much even the Defense Production Act can do to deliver doses before then.
On December 2nd, Mukul Ganguly, an eighty-three-year-old retired civil engineer in Kolkata, India, went to the Salt Lake Market to buy fish. The pandemic was surging around much of the world, and he wasn’t oblivious of the risks of spending time at a wet market.
“Variants” is the latest term to leap from the infectious disease lexicon to the general public as a result of the coronavirus, as the effects of mutations on transmission and vaccines have emerged as top global concerns.
What will it take to finally halt the spread of the coronavirus in the U.S.? To answer that question NPR created a simulation of a mock disease called SIMVID-19.
The heroic citizen-led data collection effort is finally ending. Two founders spoke to GQ about how they created a vital pandemic institution from scratch.
In the contest over who could make the most accurate coronavirus forecast, it was global institutions vs. a guy living with his parents in Santa Clara.
Every week, it would appear there is a new pandemic wall, and we are all hitting it.
Fakes and little-known brands still abound, even as health officials have advised us to up our mask game. Here’s what to do.
The answers vary by place, so NPR created a tool to help you understand how things work in your state and connect you with local resources.
The U.S. vaccine supply is poised to double in the coming weeks and months, according to an analysis by Bloomberg, allowing a broad expansion of doses administered across the country.
A Nature survey shows many scientists expect the virus that causes COVID-19 to become endemic, but it could pose less danger over time.
The country excelled during the first wave. What went wrong the second time around?
Exactly a year ago, Oxford University scientists launched a joint enterprise that is set to have a profound impact on the health of our planet.
It doesn't mean 5% of vaccinated people get infected.
How did a tiny, poor nation manage to suffer only one death from the coronavirus?
The Centers for Disease Control and Prevention released its much-anticipated, updated guidance Friday to help school leaders decide how to safely bring students back into classrooms and/or keep them there.
The number of mutations in the UK variant took scientists by surprise. Now they think its origins may lie in one person, chronically infected with the virus.
Each coronavirus contains nearly 30,000 letters of RNA. This genetic information allows the virus to infect cells and hijack them to make new viruses.
New Yorkers with tech skills were appalled when they tried to make vaccine appointments for older relatives. They knew there was a better way.
The urge to eliminate the virus is understandable — but at what cost?
America’s distribution plan is no more fair or logical than a Soviet-style queue for cabbage.
As the COVID-19 vaccine rollout gathers pace, a population is at risk of being left behind: the millions of people around the globe who lack fully functional immune systems.
C.N.A.s have questions about the speed of vaccine development, the immunity it confers, long-term side effects, and what could happen if the virus mutates further.